medRxiv preprint doi: https://doi.org/10.1101/2021.05.11.21257038; this version posted May 14, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Methods for identifying culprit drugs in cutaneous drug eruptions: A scoping review Reetesh Bose M.D., B.Sc1,2, Selam Ogbalidet3, B.Sc., B.A., Mina Boshra3, B.Sc., Alexandra Finstad3, B.Sc., B.A., Barbara Marzario M.D., B.Sc.1,2, Christina Huang, M.D., B.Sc.1,2, and Simone Fahim, MD, FRCPC, FAAD1,2,3 1. University of Ottawa, Division of Dermatology 737 Parkdale Avenue, Ottawa, ON K1Y 4M9, Canada 2. The Ottawa Hospital Division of Dermatology 737 Parkdale Avenue, Ottawa, ON K1Y 4M9, Canada 3. University of Ottawa Faculty of Medicine 451 Smyth road, Ottawa, ON, K1H8L1, Canada Corresponding Author: Dr. Reetesh Bose 737 Parkdale Avenue, Ottawa, ON K1Y 4M9, Canada Email:
[email protected] Funding statement: This article has no funding source. Conflict of interest: The authors have no conflict of interest to declare. IRB status: Exempt from review This manuscript is not being considered by any other journal or entity for publication. Abstract Word Count: 246/250 Manuscript Word Count: 3,951 / 4,500 Number of References: 150 Figures: 1 Tables: 7 Key Words: Drug rash, cutaneous adverse reaction, culprit drug identification, algorithm, causality assessment, hypersensitivity NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.